Single-dose pharmacokinetics of cefuroxime and cefamandole in healthy subjects. 1987

P A Colaizzi, and S D Goodwin, and W J Poynor, and H T Karnes, and R E Polk
Department of Pharmacy, Johns Hopkins Hospital, Baltimore, MD 21205.

UI MeSH Term Description Entries
D008297 Male Males
D002435 Cefamandole Semisynthetic wide-spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance. It is used also as the nafate. Cephamandole,Compound 83405
D002444 Cefuroxime Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS. Cephuroxime,Ketocef,Zinacef
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P A Colaizzi, and S D Goodwin, and W J Poynor, and H T Karnes, and R E Polk
August 1992, Pharmacology & toxicology,
P A Colaizzi, and S D Goodwin, and W J Poynor, and H T Karnes, and R E Polk
July 1996, Antimicrobial agents and chemotherapy,
P A Colaizzi, and S D Goodwin, and W J Poynor, and H T Karnes, and R E Polk
January 1991, European journal of clinical pharmacology,
P A Colaizzi, and S D Goodwin, and W J Poynor, and H T Karnes, and R E Polk
May 2007, British journal of clinical pharmacology,
P A Colaizzi, and S D Goodwin, and W J Poynor, and H T Karnes, and R E Polk
November 1987, Xenobiotica; the fate of foreign compounds in biological systems,
P A Colaizzi, and S D Goodwin, and W J Poynor, and H T Karnes, and R E Polk
December 1987, British journal of clinical pharmacology,
P A Colaizzi, and S D Goodwin, and W J Poynor, and H T Karnes, and R E Polk
January 1995, British journal of clinical pharmacology,
P A Colaizzi, and S D Goodwin, and W J Poynor, and H T Karnes, and R E Polk
January 1987, Biopharmaceutics & drug disposition,
P A Colaizzi, and S D Goodwin, and W J Poynor, and H T Karnes, and R E Polk
July 2015, Clinical therapeutics,
P A Colaizzi, and S D Goodwin, and W J Poynor, and H T Karnes, and R E Polk
May 1986, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!